Screener
Upstream Bio, Inc. UPB Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 36,089 | 37,865 | 72,654 | 63,662 |
| General and administrative | 7,052 | 7,419 | 15,136 | 14,201 |
| Total operating expenses | 43,141 | 45,284 | 87,790 | 77,863 |
| Loss from operations | (42,368) | (44,347) | (85,983) | (76,360) |
| Other income (expense): | ||||
| Interest income | 2,659 | 4,431 | 5,713 | 9,174 |
| Other income (expense), net | 7 | (50) | (23) | (50) |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s other operating expenses?
- Upstream Bio, Inc. (UPB) reported other operating expenses of $43.14M in Q2 2026.
- How has Upstream Bio, Inc.'s other operating expenses changed year-over-year?
- Upstream Bio, Inc.'s other operating expenses decreased by 4.7% year-over-year, from $45.28M to $43.14M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Upstream Bio, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude